| Dr Daniel L Fisher, MD | |
|
333 Red Tail Dr, Dover, DE 19904-5565 | |
| (302) 943-8040 | |
| Not Available |
| Full Name | Dr Daniel L Fisher |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 333 Red Tail Dr, Dover, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043282478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | G52296 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel L Fisher, MD 333 Red Tail Dr, Dover, DE 19904 Ph: (302) 943-8040 | Dr Daniel L Fisher, MD 333 Red Tail Dr, Dover, DE 19904-5565 Ph: (302) 943-8040 |
News Archive
The Sunnyvale, Calif.-based company Cepheid on Tuesday announced it has developed a rapid diagnostic test for tuberculosis that it will sell at a reduced cost in developing countries, the San Francisco Chronicle reports. The test was developed in partnership with the Foundation for Innovative New Diagnostics, the University of Medicine and Dentistry of New Jersey, and the National Institute of Allergy and Infectious Diseases.
The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.
Segal Institute for Clinical Research, a consortium of CNS and women's health research sites, is preparing to again be actively involved in CNS Summit this coming fall.
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.
W. L. Gore & Associates today announced it has received FDA approval for the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system.
› Verified 4 days ago
Theodore Conrad Ang Tan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 New Burton Rd, Suite 3, Dover, DE 19904 Phone: 302-730-0554 Fax: 302-730-1175 | |
Francis Lim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 419-276-1194 | |
Safwan Muhammad, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 879-022-5410 | |
Dr. Wai Wai Lin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1058 S Governors Ave Ste 101, Dover, DE 19904 Phone: 302-401-1500 Fax: 302-672-6450 | |
Abdul Muhaymin Siyal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 S Queen St, Dover, DE 19904 Phone: 302-734-7834 Fax: 302-734-7847 | |
Dr. Manmeet Brar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1198 S Governors Ave Ste B100, Dover, DE 19904 Phone: 302-734-3227 Fax: 302-734-0391 |